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Objectives
Diagnostic tests are traditionally compared for accuracy
against a gold standard, but there is growing interest in
tests (or biomarkers) used to guide treatment choices
rather than specifically to diagnose. The question of
whether health outcomes are better using one test or
another in the same population can be answered with a
randomised trial. It has been suggested that an efficient
approach to trialling is to give both tests to all partici-
pants, and randomise and follow up those with discor-
dant results. We describe how to plan and analyse such
a trial, and consider its efficiency compared with a con-
ventional trial design.
Methods
We investigated two estimates of risk difference for a
binary outcome: one based on analysing outcomes as if
from a conventional trial (the trial estimate), and one
which combined estimates of different parameters in the
manner of a decision analysis (the decision analysis esti-
mate). From theory we derived the bias and standard
error of each. We also considered the impact of rando-
mising participants to a testing strategy before the tests
are administered rather than after.
Results
The trial estimate and decision analysis estimate are
both unbiased. Using the decision analysis estimate (but
not the trial estimate) the same precision is achieved by
randomising before testing as by randomising after. Giv-
ing both tests to all participants means fewer need to be
recruited: in one example from the literature the
proposed design was nearly four times more efficient in
this sense than a conventional trial design.
Conclusions
We suggest the term “randomised discordance trial” for
the design we have described. A discordance trial offers
an efficient way to compare two diagnostic tests or bio-
markers. Randomising before testing avoids selection
bias. We have derived formulae for calculating sample
size and for estimating risk difference and standard
error using this design.
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